col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


37 Results       Page 1

 [1] 
Springer-Verlag: In Silico Pharmacology
  original article Date Title Authors   All Authors
1 [GO] 2026―Apr―17 Targeting SARS-CoV-2 main protease (3CLpro) with Paeonia-derived phytochemicals Cemal Sandalli, Safiye Merve Bostancioglu, Aytul Sandalli, Emine Akyuz Turumtay, Dana Almohazey, Moneerah Alsaeed, et al. (+8)
2 [GO] 2026―Apr―17 Modernising antiviral drug discovery: harnessing medicinal plants through machine learning and metabolomics to target the SARS-CoV-2 main protease Anathi Msobo, Pfano Witness Maphari, Gerrit Koorsen, Abdel Nasser B. Singab, Msizi I. Mhlongo
3 [GO] 2026―Feb―26 Computational screening of lichen bioactive compounds as a potential antiviral agent against SARS-CoV-2 main proteases S. Jeya Preethi, A. Yamuna, M. Arunkumar, E. Murugesh, P. Ponmurugan, P. Shanmughavel
4 [GO] 2026―Feb―19 Deciphering the potential of flavonols as SARS-CoV-2 MPro inhibitors: an in silico investigation using pass prediction, molecular docking, molecular dynamics simulation and ADMET analysis Athira E, Jibin K. Varughese, Shinta Davis, Deepthi Jose, Vijisha K. Rajan
5 [GO] 2026―Jan―28 Structure-based screening of marine carotenoids: fucoxanthin and its derivatives as potential inhibitors of the SARS-CoV-2 nucleocapsid phosphoprotein Murali Krishna Paidi, Shivaleela Biradar, T. S. Keshava Prasad
6 [GO] 2026―Jan―27 Structure-based insights into novel alkylated pyrrole and flavonoid from Dracaena reflexa as potential inhibitors of SARS-CoV-2 main and spike protease with ADME analysis Abha Shukla, Palak Kansal, Swati Vats, Ritu Tyagi, Rishi Kumar Shukla, Kishan Kishan
7 [GO] 2026―Jan―08 Mechanistic insights into the synergistic pharmacology of quercetin-kaempferol against SARS-CoV-2 infection Farman Ali, Muhammad Zubair Saleem, Muhammad Mohsin, Saleem Ahmad, Waqar Islam, Wasim Qasim, Muhammad Tayyab
8 [GO] 2025―Dec―18 Molecular docking and molecular dynamics study of PUFAs from Navicula salinicola: prospective antiviral strategies targeting the SARS-CoV-2 spike protein Aiyi Asnawi, Widhya Aligita, Ellin Febrina, Dewi Kurnia, Ivan Andriansyah, La Ode Aman
9 [GO] 2025―Nov―26 Thiuram disulfides as prospective inhibitors of 3-chymotrypsin-like cysteine protease: an in-silico approach targeting SARS-CoV-2 Segun D. Oladipo, Samuel O. Olalekan, Vincent A. Obakachi, Adesola A. Adeleke, Robert C. Luckay, Abosede A. Badeji
10 [GO] 2025―Oct―27 In silico approaches to identify therapeutic drug targets against COVID-19: a detailed review with a case study Tanmayee Basu, Atul Kumar Upadhyay
11 [GO] 2025―Oct―22 Peripheral blood, lung and brain gene signatures in recovered and deceased patients with COVID-19 Eric Twum, Ancha Baranova, Aman Ullah
12 [GO] 2025―Oct―17 Targeting SARS-CoV-2 variants with Bromelain: an in-silico study of Spike-ACE2 inhibition using docking, molecular dynamic simulation, and MM-PBSA Palash Ahuja, Lawanya Rao, Norine Dsouza
13 [GO] 2025―Sep―05 Phytocompounds of Honey mesquite (Prosopis glandulosa) and Lodhra (Symplocos racemosa) in the management of COVID-19 associated rheumatoid arthritis (CARA) Gargi Sen, Indrani Sarkar, Sandipan Ghosh, Arnab Sen
14 [GO] 2025―Sep―04 Structure-guided design and triplicate molecular dynamics evaluation of mutant peptide inhibitors targeting SARS-CoV-2 main protease (Mpro) Ankita Bhagat, Lakshmi Mounika Kelam, Nilanjan Samanta, M. Elizabeth Sobhia
15 [GO] 2025―May―31 Design and in Silico evaluation of 3’,4’-Dimethoxy flavonol as promising SARS-CoV-2 main protease (Mpro) inhibitor Neni Frimayanti, Ihsan Ikhtiarudin, Roni Ardiyansyah, Rahayu Utami, Abdi Wira Septama
16 [GO] 2024―Sep―29 Computational targeting of iron uptake proteins in Covid-19 induced mucormycosis to identify inhibitors via molecular dynamics, molecular mechanics and density function theory studies Manjima Sen, B. M. Priyanka, D. Anusha, S. Puneetha, Anagha S. Setlur, Chandrashekar Karunakaran, et al. (+3)
17 [GO] 2024―Aug―16 In silico analysis of balsaminol as anti-viral agents targeting SARS-CoV-2 main protease, spike receptor binding domain and papain-like protease receptors Daniel Danladi Gaiya, Aliyu Muhammad, Joy Sim Musa, Richard Auta, Anthony John Dadah, Rachael Oluwafunmilayo Bello, et al. (+4)
18 [GO] 2024―Mar―28 Exploring the viability of Zeatin as a prospective therapeutic candidate for investigating the complex interplay between severe acute respiratory syndrome coronavirus (SARS-CoV) and Alzheimer’s disease A. S. Sriranjini, Ashish Thapliyal, Kumud Pant
19 [GO] 2024―Feb―27 Steroidal lactones from Withania somnifera effectively target Beta, Gamma, Delta and Omicron variants of SARS-CoV-2 and reveal a decreased susceptibility to viral infection and perpetuation: a polypharmacology approach Aditi Srivastava, Rumana Ahmad, Irshad A. Wani, Sahabjada Siddiqui, Kusum Yadav, Anchal Trivedi, et al. (+4)
20 [GO] 2023―Dec―02 Design and study of bioisosteric analogues of the drug Molnupiravir as potential therapeutics against SARS-COV-2: an in silico approach Donia Ghedira, Abderrazak Aziz El Harran, Houyem Abderrazak
21 [GO] 2023―Jul―27 Development of conserved multi-epitopes based hybrid vaccine against SARS-CoV-2 variants: an immunoinformatic approach Allah Rakha Yaseen, Muhammad Suleman, Abdul Salam Qadri, Ali Asghar, Iram Arshad, Daulat Munaza Khan
22 [GO] 2023―Apr―28 Exploring the pharmacological aspects of natural phytochemicals against SARS-CoV-2 Nsp14 through an in silico approach Arkajit De, Somdatta Bhattacharya, Bishal Debroy, Arijit Bhattacharya, Kuntal Pal
23 [GO] 2022―Jul―26 Identification of vaccine candidate against Omicron variant of SARS-CoV-2 using immunoinformatic approaches Ruchika Sharma, C. R. Patil, Anoop Kumar, Kalicharan Sharma
24 [GO] 2022―Mar―14 Inhibitory effects of selected isoquinoline alkaloids against main protease (Mpro) of SARS-CoV-2, in silico study Morteza Sadeghi, Mehran Miroliaei
25 [GO] 2021―Aug―07 Identification of lead compounds from large natural product library targeting 3C-like protease of SARS-CoV-2 using E-pharmacophore modelling, QSAR and molecular dynamics simulation Olusola Olalekan Elekofehinti, Opeyemi Iwaloye, Olorunfemi R. Molehin, Courage D. Famusiwa
26 [GO] 2021―Jul―27 In-silico study of peptide-protein interaction of antimicrobial peptides potentially targeting SARS and SARS-CoV-2 nucleocapsid protein Ritu Bansal, Sanika Mohagaonkar, Anamitra Sen, Uzma Khanam, Bhawna Rathi
27 [GO] 2021―Jul―22 In silico studies of Potency and safety assessment of selected trial drugs for the treatment of COVID-19 Peter Ifeoluwa Adegbola, Olumide Samuel Fadahunsi, Aanuoluwa Eunice Adegbola, Banjo Semire
28 [GO] 2021―Jul―19 Computational assessment of select antiviral phytochemicals as potential SARS-Cov-2 main protease inhibitors: molecular dynamics guided ensemble docking and extended molecular dynamics Sanjay Sawant, Rajesh Patil, Manoj Khawate, Vishal Zambre, Vaibhav Shilimkar, Suresh Jagtap
29 [GO] 2021―Jul―01 In silico analysis of echinocandins binding to the main proteases of coronaviruses PEDV (3CLpro) and SARS-CoV-2 (Mpro) Gérard Vergoten, Christian Bailly
30 [GO] 2021―Jun―28 Prediction and identification of T cell epitopes of COVID-19 with balanced cytokine response for the development of peptide based vaccines Parul Bhatt, Monika Sharma, Sadhna Sharma
31 [GO] 2021―Apr―04 Computational screening of FDA approved drugs of fungal origin that may interfere with SARS-CoV-2 spike protein activation, viral RNA replication, and post-translational modification: a multiple target approach Rajveer Singh, Anupam Gautam, Shivani Chandel, Vipul Sharma, Arijit Ghosh, Dhritiman Dey, et al. (+3)
32 [GO] 2021―Apr―04 In search of drugs to alleviate suppression of the host's innate immune responses against SARS-CoV-2 using a molecular modeling approach Shuvasish Choudhury, Debojyoti Moulick, Anupom Borah, Purbajyoti Saikia, Muhammed Khairujjaman Mazumder
33 [GO] 2021―Jan―06 Evaluation of certain medicinal plants compounds as new potential inhibitors of novel corona virus (COVID-19) using molecular docking analysis Ayat Ahmed Alrasheid, Mazin Yousif Babiker, Talal Ahmed Awad
34 [GO] 2021―Jan―06 In silico investigation of saponins and tannins as potential inhibitors of SARS-CoV-2 main protease (Mpro) Victoria Adeola Falade, Temitope Isaac Adelusi, Ibrahim Olaide Adedotun, Misbaudeen Abdul-Hammed, Teslim Alabi Lawal, Saheed Alabi Agboluaje
35 [GO] 2021―Jan―06 Designing a conserved peptide-based subunit vaccine against SARS-CoV-2 using immunoinformatics approach Elijah Kolawole Oladipo, Ayodeji Folorunsho Ajayi, Olugbenga Samson Onile, Olumuyiwa Elijah Ariyo, Esther Moradeyo Jimah, Louis Odinakaose Ezediuno, et al. (+10)
36 [GO] 2020―Dec―04 Are losartan and imatinib effective against SARS-CoV2 pathogenesis? A pathophysiologic-based in silico study Reza Nejat, Ahmad Shahir Sadr
37 [GO] 2020―Nov―09 Peptide modelling and screening against human ACE2 and spike glycoprotein RBD of SARS-CoV-2 Shravan B. Rathod, Pravin B. Prajapati, Lata B. Punjabi, Kuntal N. Prajapati, Neha Chauhan, Mohmedyasin F. Mansuri
 [1] 

37 Results       Page 1


[de][en]

Last change 2025―Jul―29 14:55:09 UTC

© Daten-Quadrat 2022       Done in 0.008 sec